Dabrafenib, skin cancer drug, molecule

Dabrafenib, skin cancer drug, molecule

F010/4633 Royalty Free

Request un-watermarked file

Price image Pricing

Please login to use the price calculator


Caption: Dabrafenib, trade name Tafinlar, is a drug for the treatment of cancers associated with a mutated version of the gene BRAF - especially skin cancer. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf, which plays a role in the regulation of cell growth. Dabrafenib has clinical activity with a safety profile in patients with BRAF(V600)-mutated metastatic melanoma.

Release details: Model release not required. Property release not required.

Keywords: b-raf, braf, cancer, cancers, cell, dabrafenib, drug, drugs, enzyme, gene, growth, inhibitor, melanoma, molecular, mutation, regulation, skin, skin cancer, structure, tafinlar, treatment, v600

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.